|PLX -- USA Stock|| |
USD 0.43 0.0168 3.73%
Founder and Executive VP of RandD
Dr. Yoseph Shaaltiel, Ph.D., is Executive Vice President Research Development of the Protalix Biotherapeutics Inc. He founded Protalix Ltd. in 1993 and has served as our Executive Vice President, Research and Development since December 2006. From 2006 through 2014, he served on our Board of Directors. Prior to establishing Protalix Ltd., from 1988 to 1993, Dr. Shaaltiel was a Research Associate at the MIGAL Technological Center. He also served as Deputy Head of the Biology Department of the Biological and Chemical Center of the Israeli Defense Forces and as a Biochemist at Makor Chemicals Ltd. Dr. Shaaltiel was a Postdoctoral Fellow at the University of California at Berkeley and at Rutgers University in New Jersey. He has coauthored over 40 articles and abstracts on plant biochemistry and holds several patents
Age: 63 Founder Since 2016 Ph.D
972 4 988 9488 http://www.protalix.com
Shaaltiel received his Ph.D. in Plant Biochemistry from the Weizmann Institute of Science, an M.Sc. in Biochemistry from the Hebrew University and a B.Sc. in Biology from the Ben Gurion University.